Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonglin Yi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Cell International|December 9, 2020
A comparison of the efficacy of antiangiogenic agents combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysisYimin Li, Yonglin Yi, Anqi Lin, et al.
Drug Design, Development and Therapy|June 10, 2022
THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer PatientsZifu Yao, Anqi Lin, Yonglin Yi, et al.
Computational and Structural Biotechnology Journal|August 8, 2025
Integrative machine learning approach for forecasting lung cancer chemosensitivity: From algorithm to cell line validationJinghong Chen, Yonglin Yi, Chunqian Yang, et al.
Signal Transduction and Targeted Therapy|June 18, 2024
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targetsShaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Frontiers in Cell and Developmental Biology|January 28, 2022
CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based ChemotherapyYonglin Yi, Zhengang Qiu, Zifu Yao, et al.
Cancer Cell|March 11, 2025
Single-cell multi-stage spatial evolutional map of esophageal carcinogenesisJiang Chang, Junting Lu, Qingyi Liu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Cell International|December 9, 2020
A comparison of the efficacy of antiangiogenic agents combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysisYimin Li, Yonglin Yi, Anqi Lin, et al.
Drug Design, Development and Therapy|June 10, 2022
THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer PatientsZifu Yao, Anqi Lin, Yonglin Yi, et al.
Computational and Structural Biotechnology Journal|August 8, 2025
Integrative machine learning approach for forecasting lung cancer chemosensitivity: From algorithm to cell line validationJinghong Chen, Yonglin Yi, Chunqian Yang, et al.
Signal Transduction and Targeted Therapy|June 18, 2024
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targetsShaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Frontiers in Cell and Developmental Biology|January 28, 2022
CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based ChemotherapyYonglin Yi, Zhengang Qiu, Zifu Yao, et al.
Cancer Cell|March 11, 2025
Single-cell multi-stage spatial evolutional map of esophageal carcinogenesisJiang Chang, Junting Lu, Qingyi Liu, et al.
Pageof 1